DDAVP and Emicizumab-kxwh Subcutaneous
Determining the interaction of DDAVP and Emicizumab-kxwh Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: desmopressin
Brand name: DDAVP, Nocdurna, DDAVP nasal, DDAVP Rhinal Tube, Noctiva, Stimate
Synonyms: DDAVP (injection)
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- DDAVP-Emla
- DDAVP-Emla Topical
- DDAVP-Emo-Cort Scalp Solution Topical application
- DDAVP-Emo-Cort Topical application
- DDAVP-Emoquette
- DDAVP-Empagliflozin
- Emicizumab-kxwh Subcutaneous-DDAVP (Desmopressin Injection Solution)
- Emicizumab-kxwh Subcutaneous-DDAVP (Desmopressin Nasal Spray (Diabetes Insipidus))
- Emicizumab-kxwh Subcutaneous-DDAVP (Desmopressin Tablets)
- Emicizumab-kxwh Subcutaneous-DDAVP injection
- Emicizumab-kxwh Subcutaneous-DDAVP nasal
- Emicizumab-kxwh Subcutaneous-DDAVP Nasal Spray